04.17.25 -- STREAM Edition: Transform Your Drug Delivery And Manufacturing With Innovative Techniques

Gain insights pertinent to efficient and effective drug development to understand and execute a risk-based critical thinking approach related to injectable drug packaging and delivery.

Take a tour of the Pessano, Italy facility that offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, and advanced analytical capabilities.

In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.

Maximize digitalization in your organization by joining experts as they highlight the varied levels of digital maturity within companies and the importance of aligning digital initiatives with company objectives.

Discover a high-performance oligonucleotide synthesizer system that is designed for early to mid-phase clinical trials and diagnostic kit production with a compact footprint that fits in a walk-in fume hood.

Meet Jonas Nilsson, who leads a team of synthetic chemists focused on process development and optimization. He specializes in organic chemistry, process development, and impurity tracking.

Examine versatile, high-quality sachets for manufacturers and consumers with an ideal fill weight of 2 grams and above that is suitable for food or liquid formulas.

In this segment from Pharmaceutical Online Live, watch as our panelists weigh in on when to use microbial expression versus synthetic chemistry for peptide production and when a hybrid approach can be beneficial.

Uncover the capabilities of an award-winning development and manufacturing facility, which features 10 state-of-the-art GMP manufacturing suites integrated with cutting-edge R&D and QC.

See how evolving regulatory expectations in life sciences present new challenges and opportunities, as well as gain insight into strategies from experts in the field to navigate risk-based validation processes.